NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 49 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $5,249,000 | -61.0% | 3,594,568 | -27.9% | 0.00% | -66.7% |
Q3 2018 | $13,459,000 | -24.0% | 4,984,746 | -2.0% | 0.00% | -25.0% |
Q2 2018 | $17,707,000 | -31.5% | 5,088,441 | -1.0% | 0.00% | -33.3% |
Q1 2018 | $25,856,000 | +148.7% | 5,140,289 | +195.6% | 0.01% | +200.0% |
Q4 2017 | $10,397,000 | -31.7% | 1,738,696 | -6.4% | 0.00% | -33.3% |
Q3 2017 | $15,218,000 | -37.0% | 1,858,113 | -13.7% | 0.00% | -50.0% |
Q2 2017 | $24,169,000 | – | 2,152,151 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|